Work

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis in the United States

Year: 2026

Type: article

Study design: Observational Study

Source: Annals of the American Thoracic Society

DOI: 10.1093/annalsats/aaoag095

Authors: Georgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, Christopher H Goss, Raksha Jain, Wayne Morgan, Gregory S Sawicki, Michael S Schechter, Rhonda Szczesniak, Elizabeth A Cromwell, Clement L Ren

Institutions: Children's Hospital of Philadelphia, Cystic Fibrosis Foundation, University of Washington, The University of Texas Southwestern Medical Center, University of Arizona, Pulmonary Associates, Boston Children's Hospital, Virginia Commonwealth University, Children's Hospital of Richmond at VCU, Cincinnati Children's Hospital Medical Center, University of Cincinnati

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cystic Fibrosis Foundation, National Institutes of Health

Award: Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era

OpenAlex ID: W7155608952

FWCI:

Cites: 26

Cited by:

Related to: